“The White House and CDC are in a no-win position,” said David O’Connor, a professor of pathology and laboratory medicine at the University of Wisconsin. “Not only is there not a one-size-fits-all solution that they can recommend to the entire country, but there are a spectrum of reasonable options given a receding Omicron surge in late winter.”